SCHEMBL11023137

SCHEMBL11023137

CCOc1cccc(-c2ccccc2OCCCCCCCCl)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPRC P08575 1/20 0.44
▸ MAPT P10636 5/20 0.43
▸ KDM4E B2RXH2 3/20 0.43
▸ LMNA P02545 3/20 0.43
▸ MAPK1 P28482 2/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ RECQL P46063 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ ADRB2 P07550 1/20 0.43
▸ L3MBTL1 Q9Y468 4/20 0.42
▸ HTR7 P34969 1/20 0.41
▸ RXRA P19793 1/20 0.41
▸ RXRB P28702 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ THRB P10828 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ TP53 P04637 2/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ CHRM3 P20309 1/20 0.40
▸ CYP3A4 P08684 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11017667 0.88 MAPK1 (0.49) PTPRCMAPTKDM4ELMNAMAPK1
SCHEMBL11022892 0.85 L3MBTL1 (0.49) PTPRCMAPTKDM4ELMNAMAPK1
SCHEMBL10678823 0.84 RXRA (0.51) MAPTKDM4EMAPK1RXRARXRB
SCHEMBL11019719 0.83 KDM4E (0.47) KDM4EADRB2HTR7THRB
SCHEMBL11021043 0.82 RAB9A (0.50) PTPRCMAPTMAPK1KMT2AL3MBTL1
SCHEMBL10525200 0.79 TP53 (0.61) KDM4ELMNAMAPK1MEN1KMT2A
SCHEMBL11021406 0.79 TP53 (0.61) KDM4ELMNAMAPK1MEN1KMT2A
SCHEMBL11017378 0.79 TP53 (0.61) KDM4ELMNAMAPK1MEN1KMT2A
SCHEMBL11021434 0.79 TP53 (0.61) KDM4ELMNAMAPK1MEN1KMT2A
SCHEMBL11019954 0.79 TP53 (0.61) KDM4ELMNAMAPK1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0157652-A1 2-, 3- And 4-biphenyloxyaminoalkanes and related compounds, their preparation and uses, and pharmaceutical compositions containing them SYNTEX (U.S.A.) INC. (US) 1985-10-09 — — EP disclosed
Send feedback